Evaluating preclinical efficacy
- PMID: 21849661
- DOI: 10.1126/scitranslmed.3002757
Evaluating preclinical efficacy
Abstract
Recent disappointing results of clinical trials seeking type 1 diabetes (T1D) reversal suggest the need for a reevaluation of our translational efforts. This Commentary explores the need for standards in evaluating therapeutic efficacy in preclinical models of T1D.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical